Various

Analyst Upgrades and Downgrades For the Week of November 18th

Analyst upgrades, downgrades, and more

By Justin Nugent · November 19, 2024

Analyst Upgrades and Downgrades For the Week of November 18th

Upgrades – Thursday, November 21, 2024

Bank of Nova Scotia (BNS) – Barclays: Underweight >> Equal Weight
DT Midstream (DTM) – Citigroup: Neutral >> Buy, Price Target: $90 >> $115
EVERTEC (EVTC) – Morgan Stanley: Underweight >> Equal-Weight, Price Target: $33 >> $35
Palo Alto Networks (PANW) – Rosenblatt: Neutral >> Buy, Price Target: $390 >> $430
Pebblebrook Hotel Trust (PEB) – Compass Point: Neutral >> Buy, Price Target: $17
Piedmont Lithium (PLL) – Macquarie: Underperform >> Neutral, Price Target: $13.5
Royal Bank of Canada (RY) – Barclays: Equal Weight >> Overweight
SAGE Therapeutics (SAGE) – RBC Capital Markets: Underperform >> Sector Perform, Price Target: $4
AngloGold Ashanti (AU) – Scotiabank: Sector Underperform >> Sector Perform
Buenaventura SA (BVN) – Scotiabank: Sector Underperform >> Sector Perform
On (ONON) – Raymond James: Outperform >> Strong Buy, Price Target: $58 >> $63
Star Bulk Carriers (SBLK) – DNB Markets: Sell >> Hold, Price Target: $19.3 >> $20.2

Downgrades – Thursday, November 21, 2024

Adient (ADNT) – BofA Securities: Buy >> Neutral, Price Target: $30 >> $24
Grab (GRAB) – China Renaissance: Buy >> Hold, Price Target: $5.4
RBC Bearings (RBC) – BofA Securities: Buy >> Neutral, Price Target: $330 >> $335
Shopify (SHOP) – DZ Bank: Hold >> Sell
Toronto-Dominion Bank (TD) – Barclays: Equal Weight >> Underweight
Hanover Insurance (THG) – Janney: Buy >> Neutral, Price Target: $176
Travelers (TRV) – Janney: Buy >> Neutral, Price Target: $280
Ulta Beauty (ULTA) – William Blair: Outperform >> Mkt Perform
Walmart (WMT) – DZ Bank: Buy >> Hold, Price Target: $91
XPeng (XPEV) – Goldman Sachs: Buy >> Neutral, Price Target: $12.5
Pyxis Oncology (PYXS) – William Blair: Outperform >> Mkt Perform
Seven & i (SVNDF) – JP Morgan: Overweight >> Neutral
MARA Holdings Inc. (MARA) – Compass Point: Buy >> Neutral, Price Target: $21 >> $25
Innovid Corp. (CTV) – JMP Securities: Mkt Outperform >> Mkt Perform

Coverage Initiated – Thursday, November 21, 2024

Apellis Pharmaceuticals (APLS) – Morgan Stanley: Equal-Weight, Price Target: $31
Broadridge Financial (BR) – UBS: Neutral, Price Target: $250
Ensign Group (ENSG) – UBS: Buy, Price Target: $175
4D Molecular Therapeutics (FDMT) – Morgan Stanley: Underweight, Price Target: $8
GE Vernova (GEV) – Wells Fargo: Overweight, Price Target: $385
Merus (MRUS) – Goldman Sachs: Buy, Price Target: $73
Marex Group plc (MRX) – HSBC Securities: Buy, Price Target: $33
Northeast Bancorp (NBN) – Keefe Bruyette: Mkt Perform, Price Target: $102
Stardust Power (SDST) – ROTH MKM: Buy, Price Target: $13
Sunrise Communications AG (SNRE) – Deutsche Bank: Buy
UMB Financial Corporation (UMBF) – Morgan Stanley: Overweight, Price Target: $156
Vera Therapeutics (VERA) – Wells Fargo: Overweight, Price Target: $70
Amentum Holdings (AMTM) – Raymond James: Outperform, Price Target: $30
International General Insurance (IGIC) – Oppenheimer: Outperform, Price Target: $30
Mativ Holdings (MATV) – Stifel: Hold, Price Target: $15.5

Upgrades (Monday, November 18, 2024)

Amylyx Pharmaceuticals (AMLX): Robert W. Baird – Neutral >> Outperform, Price Target: $3 >> $11
Air Products (APD): UBS – Neutral >> Buy, Price Target: $375
Autolus Therapeutics (AUTL): Goldman – Neutral >> Buy, Price Target: $7 >> $7.6
Bright Horizons (BFAM): BMO Capital Markets – Market Perform >> Outperform, Price Target: $137 >> $125
CVS Health (CVS): Wells Fargo – Equal Weight >> Overweight, Price Target: $60 >> $66
Robinhood Markets (HOOD): Needham – Hold >> Buy, Price Target: $40
Hewlett Packard Enterprise (HPE): Raymond James – Outperform >> Strong Buy, Price Target: $23 >> $29
MBIA (MBI): Keefe Bruyette – Mkt Perform >> Outperform, Price Target: $6.5 >> $9
Monolithic Power (MPWR): Loop Capital – Hold >> Buy, Price Target: $660
Moderna (MRNA): HSBC Securities – Hold >> Buy, Price Target: $58
Roku (ROKU): Robert W. Baird – Neutral >> Outperform, Price Target: $70 >> $90
United Fire Group (UFCS): Piper Sandler – Underweight >> Neutral, Price Target: $19 >> $26
Franco-Nevada (FNV): Canaccord Genuity – Hold >> Buy
Futu Holdings (FUTU): Morgan Stanley – Equal-Weight >> Overweight, Price Target: $70 >> $115
Cracker Barrel (CBRL): Argus – Hold >> Buy, Price Target: $52
Dime Community (DCOM): Stephens – Equal-Weight >> Overweight, Price Target: $39
Bank of Nova Scotia (BNS): UBS – Neutral >> Buy
Aclaris Therapeutics (ACRS): Piper Sandler – Neutral >> Overweight, Price Target: $3 >> $13
Fate Therapeutics (FATE): BofA Securities – Underperform >> Neutral

Downgrades (Monday, November 18, 2024)

Biogen (BIIB): Needham – Buy >> Hold
Avis Budget (CAR): Northcoast – Buy >> Neutral
Crane (CR): Stifel – Buy >> Hold, Price Target: $176
Curtiss-Wright (CW): Stifel – Buy >> Hold, Price Target: $370
EOG Resources (EOG): Piper Sandler – Overweight >> Neutral, Price Target: $147 >> $149
ESAB Corp. (ESAB): Stifel – Buy >> Hold, Price Target: $138 >> $130
Eyenovia (EYEN): H.C. Wainwright – Buy >> Neutral, Price Target: $12 >> $2
FB Financial (FBK): Hovde Group – Outperform >> Market Perform, Price Target: $60
Ingersoll-Rand (IR): Stifel – Buy >> Hold, Price Target: $112 >> $107
Liberty Global (LBTYA): UBS – Buy >> Neutral, Price Target: $23 >> $13
Matson (MATX): Wolfe Research – Outperform >> Peer Perform
National Bank (NBHC): Hovde Group – Outperform >> Market Perform, Price Target: $55
Parker-Hannifin (PH): Stifel – Buy >> Hold, Price Target: $691
Pinnacle Finl (PNFP): Hovde Group – Outperform >> Market Perform, Price Target: $135
Pinnacle West (PNW): Barclays – Overweight >> Equal Weight, Price Target: $93 >> $91
Redfin (RDFN): Goldman – Neutral >> Sell, Price Target: $6 >> $6.5
Charles River (CRL): CLSA – Hold >> Underperform, Price Target: $164
Fortive (FTV): Argus – Buy >> Hold

Coverage Initiated (Monday, November 18, 2024)

Akero Therapeutics (AKRO): Citigroup – Buy, Price Target: $65
Astera Labs (ALAB): Citigroup – Buy, Price Target: $120
enGene Holdings (ENGN): JMP Securities – Mkt Outperform, Price Target: $18
Erasca (ERAS): Jefferies – Buy, Price Target: $6
TechnipFMC (FTI): RBC Capital Mkts – Outperform, Price Target: $37
GATX (GATX): Goldman – Buy, Price Target: $185
Ingram Micro Holding Corp. (INGM): Raymond James – Outperform, Price Target: $28
Ingram Micro Holding Corp. (INGM): Evercore ISI – In-line, Price Target: $27
Ingram Micro Holding Corp. (INGM): BofA Securities – Buy, Price Target: $30
Ingram Micro Holding Corp. (INGM): RBC Capital Mkts – Outperform, Price Target: $26
Ingram Micro Holding Corp. (INGM): Exane BNP Paribas – Neutral, Price Target: $25
Ingram Micro Holding Corp. (INGM): Jefferies – Buy, Price Target: $28
Ingram Micro Holding Corp. (INGM): Morgan Stanley – Equal-Weight, Price Target: $24
Ingram Micro Holding Corp. (INGM): Redburn Atlantic – Buy, Price Target: $30
Ingram Micro Holding Corp. (INGM): Stifel – Buy, Price Target: $28
Ingram Micro Holding Corp. (INGM): Deutsche Bank – Buy, Price Target: $26
Ingram Micro Holding Corp. (INGM): Loop Capital – Buy, Price Target: $30
Penguin Solutions (PENG): JMP Securities – Mkt Outperform, Price Target: $23
Trinity Industries (TRN): Goldman – Neutral, Price Target: $39
VYNE Therapeutics (VYNE): BTIG Research – Buy, Price Target: $8
Y-mAbs Therapeutics (YMAB): Oppenheimer – Outperform, Price Target: $23
Kanzhun Limited (BZ): CLSA – Outperform, Price Target: $18
Ingram Micro Holding Corp. (INGM): Goldman – Buy, Price Target: $33
Ingram Micro Holding Corp. (INGM): William Blair – Outperform
Arvinas (ARVN): Stephens – Overweight, Price Target: $55
Kymera Therapeutics (KYMR): Stephens – Overweight, Price Target: $65
C4 Therapeutics (CCCC): Stephens – Equal-Weight, Price Target: $4
IDEAYA Biosciences (IDYA): Stephens – Overweight, Price Target: $51
Catalyst Pharma (CPRX): Stephens – Overweight, Price Target: $35
Franco-Nevada (FNV): UBS – Buy, Price Target: $160
Wheaton Precious Metals (WPM): UBS – Buy, Price Target: $78
POET Technologies (POET): Northland Capital – Outperform, Price Target: $6
Sunrise Communications AG (SNRE): Barclays – Underweight
Sunrise Communications AG (SNRE): UBS – Buy